StockData
Bone Biologics Corp logo

Bone Biologics Corp (BBLG) stock

BBLGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 6/30
$0.29−0.02 (-5.92%)

Close on Nov 18, 2026Market cap $986.22KP/E –Yield –

Bone Biologics operating margin

Operating margin is operating income as a percentage of revenue.

Bone Biologics's operating margin for the twelve months ending Jun 30, 2021 was -0.1%. For fiscal 2020 it was -0.1%, against -0.2% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2020Dec 31, 2020-0.1%+0.2
FY2019Dec 31, 2019-0.2%+1.7
FY2016Dec 31, 2016-1.9%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2021Mar 31, 2021-0.0%–
Q1 FY2020Mar 31, 2020-0.0%–

More Bone Biologics figures

See a number that looks wrong?